• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物是如何以及何时离开其结合部位的?

How and when does an anticancer drug leave its binding site?

机构信息

Department of Chemistry, Columbia University, New York, NY 10027, USA.

Tata Institute of Fundamental Research, Center for Interdisciplinary Sciences, 21 Brundavan Colony, Narsingi, Hyderabad, India.

出版信息

Sci Adv. 2017 May 31;3(5):e1700014. doi: 10.1126/sciadv.1700014. eCollection 2017 May.

DOI:10.1126/sciadv.1700014
PMID:28580424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5451192/
Abstract

Obtaining atomistic resolution of drug unbinding from a protein is a much sought-after experimental and computational challenge. We report the unbinding dynamics of the anticancer drug dasatinib from c-Src kinase in full atomistic resolution using enhanced sampling molecular dynamics simulations. We obtain multiple unbinding trajectories and determine a residence time in agreement with experiments. We observe coupled protein-water movement through multiple metastable intermediates. The water molecules form a hydrogen bond bridge, elongating a specific, evolutionarily preserved salt bridge and enabling conformation changes essential to ligand unbinding. This water insertion in the salt bridge acts as a molecular switch that controls unbinding. Our findings provide a mechanistic rationale for why it might be difficult to engineer drugs targeting certain specific c-Src kinase conformations to have longer residence times.

摘要

从蛋白质中获得药物非结合的原子分辨率是一个备受关注的实验和计算挑战。我们使用增强采样分子动力学模拟报告了抗癌药物达沙替尼从 c-Src 激酶中的非结合动力学。我们获得了多个非结合轨迹,并确定了与实验一致的停留时间。我们观察到通过多个亚稳态中间产物的蛋白质-水耦合运动。水分子形成氢键桥,延长特定的、进化上保守的盐桥,并使配体非结合所必需的构象变化成为可能。盐桥中的这种水分子插入充当了控制非结合的分子开关。我们的发现为为什么设计针对某些特定 c-Src 激酶构象的药物以延长停留时间可能具有挑战性提供了一种机械上的解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/d987d20ffc6b/1700014-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/151d700df127/1700014-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/ce0cf04266f7/1700014-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/06fa06516697/1700014-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/d987d20ffc6b/1700014-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/151d700df127/1700014-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/ce0cf04266f7/1700014-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/06fa06516697/1700014-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/5451192/d987d20ffc6b/1700014-F4.jpg

相似文献

1
How and when does an anticancer drug leave its binding site?抗癌药物是如何以及何时离开其结合部位的?
Sci Adv. 2017 May 31;3(5):e1700014. doi: 10.1126/sciadv.1700014. eCollection 2017 May.
2
Complete reconstruction of dasatinib unbinding pathway from c-Src kinase by supervised molecular dynamics simulation method; assessing efficiency and trustworthiness of the method.通过有监督的分子动力学模拟方法对达沙替尼的 c-Src 激酶解结合途径进行完整重建;评估方法的效率和可信度。
J Biomol Struct Dyn. 2022;40(23):12535-12545. doi: 10.1080/07391102.2021.1972839. Epub 2021 Sep 2.
3
In Silico Reoptimization of Binding Affinity and Drug-Resistance Circumvention Ability in Kinase Inhibitors: A Case Study with RL-45 and Src Kinase.计算机辅助重优化激酶抑制剂的结合亲和力和耐药规避能力:以 RL-45 和Src 激酶为例的研究
J Phys Chem B. 2019 Aug 8;123(31):6664-6672. doi: 10.1021/acs.jpcb.9b02883. Epub 2019 Jul 30.
4
How does a drug molecule find its target binding site?药物分子如何找到其靶标结合位点?
J Am Chem Soc. 2011 Jun 22;133(24):9181-3. doi: 10.1021/ja202726y. Epub 2011 May 13.
5
A hot spot for protein kinase inhibitor sensitivity.蛋白激酶抑制剂敏感性的一个热点区域。
Chem Biol. 2004 May;11(5):587-9. doi: 10.1016/j.chembiol.2004.05.002.
6
An Antitumor 2-Hydroxyarylidene-4-cyclopentene-1,3-Dione as a Protein Tyrosine Kinase Inhibitor: Interaction Between TX-1123 Derivatives and Src Kinase.一种作为蛋白酪氨酸激酶抑制剂的抗肿瘤2-羟基亚芳基-4-环戊烯-1,3-二酮:TX-1123衍生物与Src激酶之间的相互作用
Anticancer Res. 2016 Jul;36(7):3645-9.
7
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.磷酸化SRC的鉴定与验证,一种针对多靶点激酶抑制剂达沙替尼(施达赛)的新型潜在药效学生物标志物。
Cancer Chemother Pharmacol. 2008 Nov;62(6):1065-74. doi: 10.1007/s00280-008-0699-5. Epub 2008 Feb 27.
8
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.体外溶出方法,微型胃肠道模拟器(mGIS),能更好地预测弱碱性药物达沙替尼的体内溶出情况。
Eur J Pharm Sci. 2015 Aug 30;76:203-12. doi: 10.1016/j.ejps.2015.05.013. Epub 2015 May 12.
9
Investigating Drug-Target Residence Time in Kinases through Enhanced Sampling Simulations.通过增强采样模拟研究激酶中的药物靶点停留时间。
J Chem Theory Comput. 2019 Aug 13;15(8):4646-4659. doi: 10.1021/acs.jctc.9b00104. Epub 2019 Jul 12.
10
How a Kinase Inhibitor Withstands Gatekeeper Residue Mutations.激酶抑制剂如何耐受关键残基突变。
J Am Chem Soc. 2016 Apr 6;138(13):4608-15. doi: 10.1021/jacs.6b01232. Epub 2016 Mar 22.

引用本文的文献

1
Thermodynamics and Kinetics of the Deintercalation of a Novel Anthracycline from Double-Stranded Oligonucleotide DNA.新型蒽环类抗生素从双链寡核苷酸DNA中脱嵌的热力学与动力学
J Phys Chem B. 2025 Aug 21;129(33):8335-8350. doi: 10.1021/acs.jpcb.5c03021. Epub 2025 Aug 12.
2
Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist.假性不可逆抑制引发了鞘氨醇 1-磷酸受体 1 拮抗剂的持久疗效。
Nat Commun. 2024 Jul 19;15(1):5743. doi: 10.1038/s41467-024-49893-8.
3
Calculating Protein-Ligand Residence Times through State Predictive Information Bottleneck Based Enhanced Sampling.

本文引用的文献

1
Mapping transiently formed and sparsely populated conformations on a complex energy landscape.在复杂的能量景观上绘制瞬态形成且分布稀疏的构象。
Elife. 2016 Aug 23;5:e17505. doi: 10.7554/eLife.17505.
2
How wet should be the reaction coordinate for ligand unbinding?配体解离的反应坐标应该有多“湿”?
J Chem Phys. 2016 Aug 7;145(5):054113. doi: 10.1063/1.4959969.
3
Impact, determination and prediction of drug-receptor residence times for GPCRs.G蛋白偶联受体(GPCRs)药物-受体驻留时间的影响、测定与预测
通过基于状态预测信息瓶颈的增强采样来计算蛋白配体驻留时间。
J Chem Theory Comput. 2024 Jul 23;20(14):6341-6349. doi: 10.1021/acs.jctc.4c00503. Epub 2024 Jul 11.
4
Mechanism of phosphate release from actin filaments.肌动蛋白丝中磷酸盐的释放机制。
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2408156121. doi: 10.1073/pnas.2408156121. Epub 2024 Jul 9.
5
Good Rates From Bad Coordinates: The Exponential Average Time-dependent Rate Approach.不良坐标下的良好速率:指数平均时间相关速率方法。
J Chem Theory Comput. 2024 Jul 23;20(14):5901-5912. doi: 10.1021/acs.jctc.4c00425. Epub 2024 Jul 2.
6
Accurate Characterization of Binding Kinetics and Allosteric Mechanisms for the HSP90 Chaperone Inhibitors Using AI-Augmented Integrative Biophysical Studies.使用人工智能增强的综合生物物理研究准确表征HSP90伴侣蛋白抑制剂的结合动力学和变构机制
JACS Au. 2024 Apr 1;4(4):1632-1645. doi: 10.1021/jacsau.4c00123. eCollection 2024 Apr 22.
7
Calculating Protein-Ligand Residence Times Through State Predictive Information Bottleneck based Enhanced Sampling.通过基于状态预测信息瓶颈的增强采样计算蛋白质-配体停留时间。
bioRxiv. 2024 Apr 20:2024.04.16.589710. doi: 10.1101/2024.04.16.589710.
8
Exploring Product Release from Yeast Cytosine Deaminase with Metadynamics.运用元动力学探究酵母胞嘧啶脱氨酶的产物释放。
J Phys Chem B. 2024 Apr 4;128(13):3102-3112. doi: 10.1021/acs.jpcb.3c07972. Epub 2024 Mar 22.
9
Enhanced Sampling with Machine Learning.利用机器学习的增强采样
Annu Rev Phys Chem. 2024 Jun;75(1):347-370. doi: 10.1146/annurev-physchem-083122-125941. Epub 2024 Jun 14.
10
Exploring Kinase Asp-Phe-Gly (DFG) Loop Conformational Stability with AlphaFold2-RAVE.利用 AlphaFold2-RAVE 探索激酶天冬氨酸-苯丙氨酸-甘氨酸(DFG)环构象稳定性。
J Chem Inf Model. 2024 Apr 8;64(7):2789-2797. doi: 10.1021/acs.jcim.3c01436. Epub 2023 Nov 20.
Curr Opin Pharmacol. 2016 Oct;30:22-26. doi: 10.1016/j.coph.2016.07.004. Epub 2016 Jul 16.
4
Multiensemble Markov models of molecular thermodynamics and kinetics.分子热力学与动力学的多系综马尔可夫模型
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3221-30. doi: 10.1073/pnas.1525092113. Epub 2016 May 25.
5
Adaptive Multilevel Splitting Method for Molecular Dynamics Calculation of Benzamidine-Trypsin Dissociation Time.用于苯甲脒-胰蛋白酶解离时间分子动力学计算的自适应多级分裂方法
J Chem Theory Comput. 2016 Jun 14;12(6):2983-9. doi: 10.1021/acs.jctc.6b00277. Epub 2016 May 18.
6
Enhancing Important Fluctuations: Rare Events and Metadynamics from a Conceptual Viewpoint.增强重要涨落:从概念角度看罕见事件与元动力学
Annu Rev Phys Chem. 2016 May 27;67:159-84. doi: 10.1146/annurev-physchem-040215-112229. Epub 2016 Mar 10.
7
How a Kinase Inhibitor Withstands Gatekeeper Residue Mutations.激酶抑制剂如何耐受关键残基突变。
J Am Chem Soc. 2016 Apr 6;138(13):4608-15. doi: 10.1021/jacs.6b01232. Epub 2016 Mar 22.
8
Spectral gap optimization of order parameters for sampling complex molecular systems.用于复杂分子系统采样的序参量的谱隙优化
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2839-44. doi: 10.1073/pnas.1600917113. Epub 2016 Feb 29.
9
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.达沙替尼的构象选择性类似物揭示了激酶抑制剂结合和选择性的相关见解。
ACS Chem Biol. 2016 May 20;11(5):1296-304. doi: 10.1021/acschembio.5b01018. Epub 2016 Mar 1.
10
A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1.一种靶向多梳抑制复合物1染色质结构域的细胞化学探针。
Nat Chem Biol. 2016 Mar;12(3):180-7. doi: 10.1038/nchembio.2007. Epub 2016 Jan 25.